Clinical Trial Update: A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2 [Phase 1, Phase 2]

View source ↗

Summary

A safety and efficacy Phase 1/2 trial of malaria vaccine candidates ChAdOx1 LS2 and MVA LS2 by the University of Oxford has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• ChAdOx1 LS2 (ChAdOx1 LS2)
• MVA LS2 (MVA LS2)

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED